Advances in the Management of Mild TBI

SUNDAY, OCTOBER 8
Time: 6:00 pm–8:00 pm | Registration, Dinner & Symposium
Location: Grand Ballroom KL | Philadelphia Marriott Downtown

Click here to register!

Grantor: Abbott Diagnostics

Speakers

Dr. Adam Goodcoff, DO
Emergency Physician, Washington, DC

Dr. Jason Wilson, MD, MA, FACEP
Division Chief, Emergency Medicine
USF Health Morsani College of Medicine, Tampa General Hospital

Dr. Beth McQuiston, MD, RD
Medical Director, Neurology
Diagnostics, Abbott

Symposium Information

Traumatic brain injury (TBI) is a staggering global problem. Historically, assessment of TBI can be very subjective. Fortunately, new, objective FDA cleared blood tests can help in the assessment of these patients. TBI patients often require unnecessary CT scans and lengthy emergency room visits. An accurate blood test can help clinicians rule out intracranial lesions, may help improve patient ED throughput, and help triage imaging resources.

Dr. Goodcoff will introduce the importance of blood tests for Brain Biomarkers and how they will help address unmet needs in the objective evaluation and assessment of patients suspected of traumatic brain injuries. Dr. Wilson, as the head of an Emergency Department, will share a real-life example of how the introduction of novel neurological biomarkers in the patient care pathway helps provide an objective rule out tool and helps reduce avoidable CT scans thereby freeing resources to care for more patients.

After this session, all participants will be able to:

• Recognize how TBI is typically assessed by clinicians
• Understand what the new TBI blood tests are measuring and how they are used to help evaluate patients
• Implement strategies to incorporate these new FDA cleared blood tests into clinical practice
• Apply an interprofessional, team-based approach to optimize TBI assessment in the emergency room